Our CVIS (Cardiovascular Information Management System) is a unique software solution that empowers you to improve the clinical and financial performance of your cardiology department. Clinical ...

CEO Alexander Macrae stated that "Sangamo continued to make significant pipeline progress in 2025 and into the first quarter of '26. Set against a backdrop of regulatory and market uncertainty and ...

Earnings call Sangamo reported significant progress in its Fabry disease program, including positive clinical data and ongoing FDA BLA submission, while raising over $130 million in 2025. However, the ...